Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes.
about
Cellular immune mechanisms in chronic autoimmune thrombocytopenic purpura (ATP).Suppression of cell-mediated immunity after infection with attenuated rubella virus.Canine migration inhibitory factor: effect of Corynebacterium parvum administrationProduction of macrophage migration inhibition factors by virus-infected cell cultures.Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytesActivation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruziRelease of endogenous pyrogen-activating factor from concanavalin A-stimulated human lymphocytes.Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products.Big and little forms of osteoclast activating factor.Human migration inhibitory factor: purification and immunochemical characterization.The role of lymphocytes and macrophages in the destruction of bone and collagen.Macrophage migration stimulation factor.Detection of activity in the conditioned medium of ethanol-treated HepG2 cells which stimulates collagen synthesis in IMR-90 cells.Studies on mediator production by highly purified human T and B lymphocytes.Lymphoid cell lines as indicators of lymphokine generation.Macrophage migration inhibitory factor (MIF) in guinea pigs and humans with delayed hypersensitivity.The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.Cytolytic Activity Of Tonsil Cells
P2860
Q33358576-11E0A311-6747-4AF1-947F-2540071B5222Q34387712-2570F6A0-4297-443E-B430-93A5384F8FBEQ34416153-BABD3CC4-0FD4-4794-9E82-9B56E09292C0Q34492467-538C88C5-DDED-41C4-BB22-995DDEE68C1FQ34518102-7A944FED-E344-4834-B485-510DE5BD6C5BQ36341492-28EFD169-D892-4AB3-8472-DA75E0221E91Q36344313-33CB3DE7-E345-4E1C-BD7D-F2C08710C3CFQ36360244-AAEBBF60-BEDA-4ED0-801B-08C2067B8BBDQ37045505-7A0DE396-F5E3-40F6-8439-D026CA0E8F70Q39475775-4B02EAAB-C5DF-4980-AE06-F3F329831280Q39950199-41B02D4D-B775-41FD-B1D4-13A6DDA9BFB5Q40326613-1146B667-8663-4C2D-A5B6-29DC10C29C02Q41233060-91D3B7CE-97D3-4771-BD51-70AFF1EB346AQ42837088-DE9EF622-B26A-484D-9067-10730B404362Q43555232-E1E597DC-00FC-4CCD-B0F3-A242C82B70ECQ46481235-3246501C-55A0-4F88-A1DE-EFD372DDE334Q53845311-B923A768-A974-4138-B391-40A27BB4EEA1Q58291188-68D169E5-AE78-41FF-A8D1-156F1A792DAF
P2860
Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh-hant
name
Characterization of human migr ...... ntigen-stimulated lymphocytes.
@en
Characterization of human migration inhibitory factor
@nl
type
label
Characterization of human migr ...... ntigen-stimulated lymphocytes.
@en
Characterization of human migration inhibitory factor
@nl
prefLabel
Characterization of human migr ...... ntigen-stimulated lymphocytes.
@en
Characterization of human migration inhibitory factor
@nl
P2093
P1433
P1476
Characterization of human migr ...... ntigen-stimulated lymphocytes.
@en
P2093
H G Remold
R E Rocklin
P304
P356
10.1016/0008-8749(72)90070-6
P577
1972-11-01T00:00:00Z